Hematopoietic stem cell transplantation following unsuccessful salvage treatment for relapsed acute lymphoblastic leukemia in children
Author:
Affiliation:
1. Department of Pediatrics; National Kyushu Cancer Center; Fukuoka Japan
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology, and Child Health
Reference31 articles.
1. Outcome of children and adolescents with relapsed acute lymphoblastic leukemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group;von Stackelberg;Eur J Cancer,2011
2. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: A therapeutic advances in childhood leukemia consortium study;Ko;J Clin Oncol,2010
3. Long-term follow-up of relapsed childhood acute lymphoblastic leukemia;Chessells;Br J Haematol,2003
4. Childhood acute lymphoblastic leukemia and relapse;Gaynon;Br J Haematol,2005
5. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure;Duval;J Clin Oncol,2010
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph+ B cell acute lymphoblastic leukemia;Frontiers in Immunology;2022-09-26
2. Chimeric Antigen Receptor T Cell Therapy followed by Unrelated Cord Blood Transplantation for the Treatment of Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia in Children and Young Adults: Superior Survival but Relatively High Post-Transplantation Relapse;Transplantation and Cellular Therapy;2022-02
3. Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea;Cancer Research and Treatment;2021-10-15
4. Sarcopenia and obesity in long-term survivors of childhood leukemia/lymphoma: a report from a single institution;Japanese Journal of Clinical Oncology;2021-04-06
5. Efficacy and Safety of Inotuzumab Ozogamicin (CMC-544) for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3